• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Comprehensive Overview of (6-((Tetrahydro-2H-pyran-4-yl)-oxy)pyridin-3-yl)boronic acid (CAS No. 1028745-48-3)

(6-((Tetrahydro-2H-pyran-4-yl)-oxy)pyridin-3-yl)boronic acid (CAS No. 1028745-48-3) is a highly versatile boronic acid derivative widely used in pharmaceutical research, organic synthesis, and material science. This compound belongs to the class of heterocyclic boronic acids, which are pivotal in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic chemistry. Its unique structure, featuring a tetrahydro-2H-pyran-4-yl ether linkage and a pyridin-3-yl boronic acid moiety, makes it a valuable intermediate for designing novel drug candidates and functional materials.

The growing interest in (6-((Tetrahydro-2H-pyran-4-yl)-oxy)pyridin-3-yl)boronic acid is driven by its applications in targeted drug discovery, particularly in oncology and neurodegenerative diseases. Researchers are exploring its potential as a proteolysis-targeting chimera (PROTAC) component, a cutting-edge technology for degrading disease-causing proteins. Additionally, its role in bioconjugation and click chemistry aligns with the rising demand for precision medicine and diagnostic tools.

From a synthetic perspective, CAS No. 1028745-48-3 is prized for its stability and reactivity under mild conditions, making it ideal for green chemistry initiatives. Its compatibility with aqueous and aerobic environments addresses sustainability concerns, a hot topic in the chemical industry. Recent studies highlight its utility in metal-free catalysis and photoredox reactions, further enhancing its appeal for eco-friendly synthesis.

In material science, (6-((Tetrahydro-2H-pyran-4-yl)-oxy)pyridin-3-yl)boronic acid is investigated for organic electronics and sensor development. Its ability to form stable complexes with diols and sugars enables applications in glucose sensing and bioimaging, catering to the expanding wearable health tech market. The compound’s fluorescence properties are also leveraged in designing molecular probes for real-time cellular monitoring.

Quality and purity are critical for CAS No. 1028745-48-3, with HPLC and NMR being standard characterization techniques. Suppliers often provide customized formulations, including lyophilized powders or solution-phase variants, to meet diverse research needs. Storage recommendations typically emphasize protection from moisture and light to preserve its boronic acid functionality.

As the demand for high-value chemical intermediates surges, (6-((Tetrahydro-2H-pyran-4-yl)-oxy)pyridin-3-yl)boronic acid continues to gain traction in academic and industrial labs. Its integration into AI-driven drug design platforms and combinatorial libraries underscores its future potential. For researchers seeking reliable data, peer-reviewed journals and patent databases are essential resources for exploring its latest applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)